BioSpace

Biotech VC Forbion raises record $2.6B to support 30 ‘high-potential’ companies

Forbion participated in the November 2025 series B round of Gate Bioscience, which earlier this week inked an up to $870 million deal extension with Eli Lilly.

By BioSpace

1 min read
Biotech VC Forbion raises record $2.6B to support 30 ‘high-potential’ companies
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights